To further evaluate the clinical correlation between p-ERK1/2 and PrLZ, we performed immunohistochemistry (IHC) staining in 128 PCa patient samples and found a strong correlation (Rho = 0.596, P < 0.01) between the two sets (Fig. 5r, s). The gene discussed is TPD52; the disease is posterior cortical atrophy.